IMC Chicago’s Quest Diagnostics DGX Stock Holding History

IMC Chicago’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.25M	Sell	16,600 -700	-4%	-$136K	﹤0.01%	2159
2025 Q4	$3M	Sell	17,300 -1,900	-10%	-$346K	﹤0.01%	2110
2025 Q3	$3.66M	Sell	19,200 -7,600	-28%	-$1.35M	﹤0.01%	1800
2025 Q2	$4.81M	Buy	26,800 +4,100	+18%	+$712K	﹤0.01%	1413
2025 Q1	$3.84M	Buy	+22,700	New	+$3.73M	﹤0.01%	1380

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

IMC Chicago's DGX Position: Q1 2026 in Review

IMC Chicago opened a new position in Quest Diagnostics (DGX) in Q1 2026: 5,227 shares worth $1.02M. The stake represents ﹤0.01% of the portfolio and ranks #3255 among its holdings.

1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

IMC Chicago held 5,227 shares of Quest Diagnostics worth $1.02M as of Q1 2026.
Quest Diagnostics was a new IMC Chicago position in Q1 2026.
Quest Diagnostics made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #3255 holding.
1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.